X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor−Ligand Binding Domain
Keith Biggadike, Randy K. Bledsoe, Anne M. Hassell et al. · Journal of Medicinal Chemistry · 2008
An X-ray crystal structure is reported for the novel enhanced-affinity glucocorticoid agonist fluticasone furoate (FF) in the ligand binding domain of the glucocorticoid receptor. Comparison of this structure with those of dexamethasone and fluticasone propionate shows the 17 alpha furoate ester to occupy more fully the lipophilic 17 alpha pocket on the receptor, which may account for the enhanced glucocorticoid receptor binding of FF.
Cited by 110 works. doi:10.1021/jm800279t
Authors
- Keith Biggadike
- Randy K. Bledsoe
- Anne M. Hassell
- Barrie E. Kirk
- Iain M. McLay
- Lisa M. Shewchuk
- Eugene L. Stewart
References
- The CCP4 suite: programs for protein crystallography
- Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
- The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure
- Atomic structure of progesterone complexed with its receptor
- Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition
- The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain
- Mometasone Furoate
- Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis
- Synthesis and Structure-Activity Relationships in a Series of Antiinflammatory Corticosteroid Analogs, Halomethyl Androstane-17.beta.-carbothioates and -17.beta.-carboselenoates
- Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen